Alerts will be sent to your verified email
Verify Email
CBPL
|
Chandra Bhagat Pharm
|
Ishita Drugs & Inds.
|
Unick Fix-A-Form
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
3.03 % | 8.38 % | 8.1 % |
|
5yr average Equity Multiplier
|
2.92 | 1.27 | 2.38 |
|
5yr Average Asset Turnover Ratio
|
1.46 | 1.23 | 0.87 |
|
5yr Avg Net Profit Margin
|
0.71 % | 5.43 % | 3.9 % |
|
Price to Book
|
0.0 | 2.14 | 0.7 |
|
P/E
|
27.79 | 26.94 | 11.61 |
|
5yr Avg Cash Conversion Cycle
|
123.14 Days | 74.52 Days | 35.77 Days |
|
Inventory Days
|
97.15 Days | 35.08 Days | 63.15 Days |
|
Days Receivable
|
158.67 Days | 31.6 Days | 70.74 Days |
|
Days Payable
|
38.34 Days | 42.7 Days | 123.98 Days |
|
5yr Average Interest Coverage Ratio
|
1.63 | 24.46 | 2.43 |
|
5yr Avg ROCE
|
10.9 % | 11.48 % | 12.53 % |
|
5yr Avg Operating Profit Margin
|
1.16 % | 6.66 % | 14.0 % |
|
5 yr average Debt to Equity
|
0.76 | 0.09 | 0.78 |
|
5yr CAGR Net Profit
|
35.25 % | 0.95 % | 2.3 % |
|
5yr Average Return on Assets
|
1.04 % | 6.68 % | 3.39 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.02 % | 50.04 % | 71.57 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
2.6 % | 0.66 % | 35.93 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Chandra Bhagat Pharm
|
Ishita Drugs & Inds.
|
Unick Fix-A-Form
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
-
|